Safi Biotherapeutics Inc Press Releases - EIN Presswire - Press Release Distribution Service

Published on April 24, 2025 - 12:00 GMT

Safi Biotherapeutics Awarded NIH STTR Grant to Improve Blood Transfusion Safety

Safi to bulk manufacture Children’s Hospital of Philadelphia’s iPSC-derived RBCs with rare antigen profiles as diagnostic tools for alloimmunized patients CAMBRIDGE, MA, UNITED STATES, April 24, 2025 /⁨EINPresswire.com⁩/ -- Safi Biotherapeutics, a …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 25, 2025 - 13:00 GMT

U.S. DoD Awards Safi Biotherapeutics $3.5 Million in Additional Non-Dilutive Funding to Optimize Cryo-Storage of mRBCs

Safi advancing manufactured human RBC (mRBC) program for acute bleeding and chronic transfusion indications CAMBRIDGE, MA, UNITED STATES, February 25, 2025 /⁨EINPresswire.com⁩/ -- Safi Biotherapeutics, a biotech company producing stem-cell derived, human …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on February 10, 2025 - 13:00 GMT

Safi Biotherapeutics and ARMI | BioFabUSA Initiate Collaboration to Support Large-Scale Development of mRBCs

Partnership focused on transitioning Safi manufactured human red blood cells (mRBCs) to cGMP manufacturing at a clinically meaningful scale CAMBRIDGE, MA, UNITED STATES, February 10, 2025 /⁨EINPresswire.com⁩/ -- Safi Biotherapeutics, a biotech company …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on December 18, 2024 - 13:15 GMT

Safi Biotherapeutics Granted Rare Pediatric Disease Designation and Orphan Drug Designation from the U.S. FDA

Designations support use of manufactured red blood cells in sickle cell disease chronic transfusion therapy CAMBRIDGE, MA, UNITED STATES, December 18, 2024 /⁨EINPresswire.com⁩/ -- Safi Biotherapeutics, a biotech company producing stem-cell derived, human …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on September 11, 2024 - 20:00 GMT

Safi Biotherapeutics Secures $5M in Seed Funding to Accelerate Plans to Grow Blood for Acute and Chronic Transfusions

Developer of world-leading capabilities in the hyper-efficient production of manufactured red blood cells at viable economics. CAMBRIDGE, MA, UNITED STATES, September 11, 2024 /⁨EINPresswire.com⁩/ -- Founded by former DARPA, Vertex, MIT, and MGH leaders, …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on January 5, 2024 - 13:00 GMT

Safi Biotherapeutics Solidifies Leading Position in Red Blood Cell Biomanufacturing with Acquisition of EryPharm Assets

CAMBRIDGE, MA, UNITED STATES, January 5, 2024 /⁨EINPresswire.com⁩/ -- Safi Biotherapeutics (“Safi”), a leader in the field of allogeneic biomanufacture of blood cells, proudly announces the successful completion of an agreement to acquire all assets of …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on August 4, 2022 - 09:00 GMT

Safi Biosolutions rebranding as Safi Biotherapeutics

CAMBRIDGE, MA, UNITED STATES, August 4, 2022 /⁨EINPresswire.com⁩/ -- To better align with Safi Biosolution’s noble and ambitious mission to produce blood cells at multi-unit transfusion scale with viable economics for therapeutic indications, the company …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on March 24, 2022 - 16:00 GMT

Safi Biosolutions developing alternatives to donated blood as part of USU 4D Bio3 On-Demand Blood program

CAMBRIDGE, MA, UNITED STATES, March 24, 2022 /⁨EINPresswire.com⁩/ -- The Geneva Foundation (Geneva), a 501(c)3 non-profit that provides innovative scientific research and exceptional program management, recently announced the award of an additional $12 …

Distribution channels: Healthcare & Pharmaceuticals Industry ...